Literature DB >> 18032528

NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II.

Lijuan L Shang1, Shamarendra Sanyal, Arnold E Pfahnl, Zhe Jiao, Jon Allen, Hong Liu, Samuel C Dudley.   

Abstract

Angiotensin II (ANG II) increases oxidative stress and is associated with increased risk of sudden cardiac death. The cardiac Na(+) channel promoter contains elements that confer redox sensitivity. We tested the hypothesis that ANG II-mediated oxidative stress may modulate Na(+) channel current through altering channel transcription. In H9c2 myocytes treated for 48 h with ANG II (100 nmol/l) or H(2)O(2) (10 micromol/l) showed delayed macroscopic inactivation, increased late current, and 59.6% and 53.8% reductions in Na(+) current, respectively (P < or = 0.01). By quantitative real-time RT-PCR, the cardiac Na(+) channel (scn5a) mRNA abundance declined by 47.3% (P < 0.01) in H9c2 myocytes treated for 48 h with 100 nmol/l ANG II. A similar change occurred with 20 micromol/l H(2)O(2) (46.9%, P < 0.01) after 48 h. Comparable effects were seen in acutely isolated ventricular myocytes. The effects of ANG II could be inhibited by prior treatment of H9c2 cells with scavengers of reactive oxygen species or an inhibitor of the NADPH oxidase. Mutation of the scn5a promoter NF-kappaB binding site prevented decreased activity in response to ANG II and H(2)O(2). Gel shift and chromosomal immunoprecipitation assays confirmed that nuclear factor (NF)-kappaB bound to the scn5a promoter in response to ANG II and H(2)O(2). Overexpression of the p50 subunit of NF-kappaB in H9c2 cells reduced scn5a mRNA (77.3%, P < 0.01). In conclusion, ANG II can decrease scn5a transcription and current. This effect appears to be through production of H(2)O(2) resulting in NF-kappaB binding to the Na(+) channel promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032528      PMCID: PMC3150844          DOI: 10.1152/ajpcell.00186.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  49 in total

Review 1.  The antiarrhythmic potential of angiotensin II antagonism: experience with losartan.

Authors:  I Gavras; H Gavras
Journal:  Am J Hypertens       Date:  2000-05       Impact factor: 2.689

Review 2.  The role of the persistent Na(+) current during cardiac ischemia and hypoxia.

Authors:  David A Saint
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

3.  NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin.

Authors:  Fuzhong Qin; Ravish Patel; Chen Yan; Weimin Liu
Journal:  Free Radic Biol Med       Date:  2005-11-10       Impact factor: 7.376

4.  Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice.

Authors:  Talin Ebrahimian; Ying He; Ernesto L Schiffrin; Rhian M Touyz
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

5.  A possible mechanism of halocarbon-induced cardiac sensitization arrhythmias.

Authors:  Zhe Jiao; Víctor R De Jesús; Shahriar Iravanian; Daniel P Campbell; Jie Xu; Juan A Vitali; Kathrin Banach; John Fahrenbach; Samuel C Dudley
Journal:  J Mol Cell Cardiol       Date:  2006-08-17       Impact factor: 5.000

Review 6.  Role of oxidative stress in cardiovascular diseases.

Authors:  N S Dhalla; R M Temsah; T Netticadan
Journal:  J Hypertens       Date:  2000-06       Impact factor: 4.844

7.  Free oxygen radicals contribute to high incidence of reperfusion-induced arrhythmias in isolated rat heart.

Authors:  T Ravingerová; J Slezák; N Tribulová; A Dzurba; B Uhrík; A Ziegelhöffer
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium.

Authors:  T Ide; H Tsutsui; S Kinugawa; N Suematsu; S Hayashidani; K Ichikawa; H Utsumi; Y Machida; K Egashira; A Takeshita
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

9.  Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel.

Authors:  Lijuan L Shang; Arnold E Pfahnl; Shamarendra Sanyal; Zhe Jiao; Jon Allen; Kathrin Banach; John Fahrenbach; Daiana Weiss; W Robert Taylor; A Maziar Zafari; Samuel C Dudley
Journal:  Circ Res       Date:  2007-09-27       Impact factor: 17.367

10.  Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury.

Authors:  William E Stansfield; Nancy C Moss; Monte S Willis; Ruhang Tang; Craig H Selzman
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

View more
  53 in total

1.  Mitochondria-derived superoxide and voltage-gated sodium channels in baroreceptor neurons from chronic heart-failure rats.

Authors:  Huiyin Tu; Jinxu Liu; Zhen Zhu; Libin Zhang; Iraklis I Pipinos; Yu-Long Li
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

Review 2.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

3.  Deletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and β3 subunit.

Authors:  Benzhi Cai; Ning Wang; Weike Mao; Tao You; Yan Lu; Xiang Li; Bo Ye; Faqian Li; Haodong Xu
Journal:  J Mol Cell Cardiol       Date:  2014-06-21       Impact factor: 5.000

Review 4.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

5.  Angiotensin II and oxidative stress in the failing heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

6.  Elevated nuclear Foxo1 suppresses excitability of skeletal muscle fibers.

Authors:  Erick O Hernández-Ochoa; Tova Neustadt Schachter; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

Review 7.  The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.

Authors:  Shahriar Iravanian; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2008-03-04       Impact factor: 6.343

8.  Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas
Journal:  Ochsner J       Date:  2013

Review 9.  NADPH oxidases and angiotensin II receptor signaling.

Authors:  Abel Martin Garrido; Kathy K Griendling
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

10.  Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.

Authors:  Nona Sotoodehnia; Guo Li; Catherine O Johnson; Rozenn N Lemaitre; Kenneth M Rice; Thomas D Rea; David S Siscovick
Journal:  Heart Rhythm       Date:  2009-06-09       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.